Author

Wei Gao

University of HoustonORCID 0000-0002-5233-3734Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Wei Gao2 papers · The University of Melbourne

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Chengyi LiiD· 2 shared Duxin SuniD· 2 shared Fang KeiD· 2 shared Hanning Wen· 2 shared Alejandro BalsaiD· 1 shared Alexandra K. MouraiD· 1 shared Bo WeniD· 1 shared Dan WangiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Chengyi LiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates

Rui Zuo, Mi Wang, Y Q Wang, Jenny Z. Hu, Alexandra K. Moura, Dan Wang, Pin-Lan Li, Mingfu Wu, Tahir Hussain, Wei Gao, Xiang Li, Yang Zhang

This paper develops a computational platform to repurpose drugs for liver fibrosis by focusing on LSECs, identifying vorinostat and other candidates that protect LSECs.

bioRxiv · May 27, 2026 · PreprintPharmacology & Toxicology

Albumin-STING Nanoagonist Reprograms HSPCs to Antitumor Neutrophils Enhancing MHC I-Mediated CD8+ T Cell Immunity

Jinsong Tao, Hongyi Zhao, Chengyi Li, Hanning Wen, Fang Ke, Qiuxia Li, Miao He, Bo Wen, Zhongwei Liu, Wei Gao, Duxin Sun

This paper shows that an albumin-STING nanoagonist reprograms hematopoietic stem/progenitor cells into antitumor neutrophils, enhancing CD8+ T cell immunity against tumors.

bioRxiv · Sep 2, 2025 · PreprintImmunology

SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation

Chengyi Li, Fang Ke, Shuai Mao, Zera Montemayor, Mohamed Dit Mady Traore, Alejandro Balsa, Mahamadou Djibo, Neha Karekar, Hongxiang Hu, Hanning Wen, Wei Gao, Duxin Sun

This study develops a neoantigen vaccine using SARS-CoV-2 B cell epitopes to enhance CD4/CD8 T cell immunity through B cell antigen presentation, showing improved efficacy in multiple cancer models.

ACS Nano · Feb 13, 2025Peer-reviewedImmunology